project id: TCGA-KIRC; case submitter id: TCGA-MW-A4EC; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.0; rna integrity number: 8.0; age at index: 72; days to birth: -26649; ethnicity: hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1940; age at diagnosis: 26649; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 498.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8312/3; primary diagnosis: Renal cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 190; initial weight: 110.0; sample id: b3fb041e-e2f7-4aea-b08d-3aab3537ba3a; sample submitter id: TCGA-MW-A4EC-01A; portion id: 58a266dc-7790-44c4-a513-01d299ee6907; portion submitter id: TCGA-MW-A4EC-01A-11; slide id: 3b78c473-2711-478c-8004-b6cae5fa8357; slide submitter id: TCGA-MW-A4EC-01A-01-TSA; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;